loading

Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
49.03%
5.529
3.71 3.67 4.887 3.976
Operating Income/Loss
49.03%
-5.529
-3.71 -3.67 -4.887 -3.976
Nonoperating Income/Loss
17.84%
-0.921
-1.121 -2.887 -1.071 -0.99
Income/Loss From Continuing Operations Before Tax
33.51%
-6.45
-4.831 -6.557 -5.958 -4.966
Income Tax Expense/Benefit
1.67%
0.059
0.06 0.025 0.136 0.031
Income/Loss From Continuing Operations After Tax
33.08%
-6.509
-4.891 -6.582 -6.094 -4.997
Net Income/Loss
33.08%
-6.509
-4.891 -6.582 -6.094 -4.997
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
17.25%
39.94
34.06 2.3463 20.04 16.55
Diluted Average Shares
17.25%
39.94
34.06 2.3463 20.04 16.55
Basic Earnings Per Share
14.29%
-0.16
-0.14 -0.21 -0.30 -0.30
Diluted Earnings Per Share
14.29%
-0.16
-0.14 -0.21 -0.30 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.32
price up icon 0.98%
$27.45
price up icon 0.27%
$25.61
price up icon 7.56%
$110.50
price up icon 7.16%
$143.55
price up icon 0.77%
biotechnology ONC
$338.15
price up icon 6.25%
Kapitalisierung:     |  Volumen (24h):